使用已建立的癌症干细胞系和药物发现,对瘤复发的分子分析
Kiyotaka Nakano1, Eiji Oki2,3, Masaki Yamazaki1
1Translational Research Division, Chugai Pharmaceutical Co., Ltd., Chugai Life Science Park Yokohama, 216 Totsuka-Cho, Totsuka-Ku, Yokohama, Kanagawa, 244-8602, Japan.
International journal of clinical oncology
|January 20, 2026
概括
结肠直肠癌复发是由耐治疗的癌症干细胞驱动的. 一种新的RNA聚合酶I抑制剂,BMH-21,通过向这些耐药细胞,有效地抑制瘤复发.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症干细胞研究研究
背景情况:
- 结肠直肠癌 (CRC) 复发,由最小的残留疾病驱动,尽管有辅助疗法,仍然是一个重要的临床挑战.
- 癌症干细胞 (CSC) 假设认为,耐治疗的CSC亚群驱动瘤复发.
研究的目的:
- 研究癌症干细胞在CRC复发中的作用.
- 确定针对CSC驱动的抗性的新型治疗策略.
主要方法:
- 开发LGR5特异性单克隆抗体和免疫光,用于在临床瘤中可视化LGR5.
- 建立了PLR123结直肠癌细胞系,具有强大的干细胞特性.
- 利用单细胞RNA测序和小分子查用于药物发现.
主要成果:
- 确定了RNA聚合酶I抑制剂BMH-21作为瘤复发的强有力的抑制剂.
- 在结直肠癌复发的体外和体内模型中,BMH-21的疗效得到了证明.
- 阐明了CSC驱动电阻的机制.
结论:
- 向癌症干细胞对于预防结直肠癌复发至关重要.
- BMH-21代表了一种有前途的治疗药物,可以克服CSC介导的耐药性,并防止瘤复发.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Drug Discovery: Overview
11.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.2K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Adult Stem Cells
33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Embryonic Stem Cells
32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K


